Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Pharmacy and Pharmacology|August 24, 1999
Thromboxane A2 receptor antagonism in man and rat by a sulphonylcyanoguanidine (BM-144) and a sulphonylurea (BM-500)B Masereel, J Damas, J Fontaine, et al.
Pharmacological Research|January 13, 1998
JL13, a pyridobenzoxazepine compound with potential atypical antipsychotic activity: a review of its behavioural propertiesJ Bruhwyler, J F Liégeois, J Bergman, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 7, 2000
Effects of a novel non-carboxylic thromboxane A2 receptor antagonist (BM-531) derived from torasemide on platelet functionJ M Dogné, X de Leval, P Neven, et al.
Archives of Physiology and Biochemistry|January 24, 1998
Effect of potassium channel openers on the firing rate of hippocampal pyramidal cells and A10 dopaminergic neurons in vitroJ Scuvée-Moreau, V Seutin, B Vrijens, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 23, 2003
Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregationX de Leval, V Benoit, J Delarge, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 10, 1998
Pyridothiadiazinedioxides structurally related to quinazolinones cholecystokinin/gastrin receptor ligands: synthesis and biological evaluationB Pirotte, P de Tullio, T Podona, et al.
European Journal of Medicinal Chemistry|October 16, 2001
Novel inhibitors of the sodium-calcium exchanger: benzene ring analogues of N-guanidino substituted amiloride derivativesF Rogister, D Laeckmann, P Plasman, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Activation of ATP-dependent K+ channels and inhibition of insulin release: effect of BPDZ 62P Lebrun, M H Antoine, R Ouedraogo, et al.
Pageof 7